4th Project Meeting: Berlin
The fourth sysVASC project meeting was held on 24-25th January 2017 and hosted by Charité in Berlin. All partners had the opportunity to discuss their progress and outline their plans for the final year of the project.
Thirty-one representatives from fourteen partner institutions were present at the fourth sysVASC project meeting which was held on 24-25th January 2017 in Berlin, Germany.
This meeting provided all partners with the opportunity to present their progress within each work package to which they contribute. The meeting focused on discussing existing difficulties and mapping out a clear path towards successful completion of project objectives in the final year of the project.
As the project moves into its final year the partners were keen to establish concrete plans and timelines to ensure that the great work achieved during the first three years of the project is capitalised on. The partners left the meeting optimistic and energised with a feasible plan in place to achieve a successful conclusion to the project.
Scientific Meeting: Glasgow
On 9th and 10th of May members of the sysVASC Consortium met in Glasgow to discuss the progress of the project and to decide upon the next steps. Twenty four participants representing almost all sysVASC partners attended the meeting at the BHF Glasgow Cardiovascular Research Centre.
The overall aim of the sysVASC programme is to identify targets for the future therapy of vascular diseases. Over the past two years, detailed molecular analyses and comparisons between human disease and experimental models have been performed and this meeting allowed the Consortium to discuss the implications of these findings in depth.
Presentations were held on data derived from experimental models, large-scale human data and the tools that have been developed to facilitate analyses (ranging from dedicated databases to sophisticated bioinformatic methods). The meeting provided sufficient time to discuss the findings and to decide upon future directions.
A follow-up meeting in six months' time is planned. In the meantime sysVASC partners will further intensify the collaboration within the Consortium but also between specific partners in order to achieve defined outputs.
3rd Project Meeting: Athens
The third sysVASC project meeting was held on 16-17th March 2016 and hosted by the Biomedical Research Foundation in Athens. All work package leaders had the opportunity to discuss progress during the first half of the project and outline their plans for the future.
Thirty-five representatives from all project partner institutions were present at the third sysVASC project meeting which was held on 16-17th March 2016 in Athens, Greece.
This meeting provided all work package leaders with the opportunity to present progress within their work packages during the first half of the project, to discuss difficulties and potential solutions and to introduce roadmaps towards successful completion of project objectives within the time remaining.
The project has an ambitious timeline ahead of it to build on the great work and progress achieved during the first two years. The project partners were positive and determined that the project is capable of achieving the progress required in the next two years and reaching a successful outcome.
2nd Project Meeting: Geneva
The second sysVASC meeting was held on 23-24th February 2015 in Geneva, Switzerland. All partners had the opportunity to discuss their progress during the first year and outline their plans for the future.
Thirty-six representatives from all project partner institutions were present at the second sysVASC project meeting which was held on 23-24th February 2015 in Geneva, Switzerland.
This meeting provided all partners with the opportunity to present their progress during the first year, to discuss difficulties and potential solutions and to look ahead to their plans for the future.
The project has progressed well during the first year in terms of the successful implementation of the technical set-up. The project partners were positive that the project has made a great start and that the plans in place will enable this progress to continue in the second year.
For the 4th consecutive year, on 10 April, Inserm has opened the doors of its laboratories to students from primary to high school, in several cities in France. The operation “Destination Labo” gives annual opportunity for school to come discover the world of biomedical research and exchange with researchers, engineers and technicians on their job in order to refine their career plans and encourage vocations. A window on the usually impenetrable places!
In Toulouse, the Institute of metabolic and cardiovascular diseases (INSERM UMR / UPS 1048 – I2MC) hosted one class of the “Lycée Pierre Bourdieu” in Fronton. The program was made of mini-lectures, direct exchanges, experimental workshops … The Renal Fibrosis laboratory (http://renalfibrosis.fr/) actively participated in the operation, presenting all their current work regarding chronic kidney disease and its association to cardiovascular disease, with a special emphasis on the SysVasc project.
MUG 10-year anniversary:
As part of its 10-year anniversary, on the 17th of october 2014, the MUG also introduces the sysVASC public to the public. 3.000 visitors celebrated under the heading "Medical University Graz in the centre" at the mains quare in Graz.
Try to solve the sysVASC postcard quiz:
Read more about the event ath the offical MUG homepage (german only):
See the sysVASC poster (german only):
Kick-off meeting: Graz
The Kick-off meeting was successfully held on February 17-18th, 2014 in Graz, Austria where each partner had the opportunity to discuss their road map of activities for the first year.
The Kick-off meeting for the sysVASC project was successfully held on February 17-18th, 2014 in Graz, Austria. Thirty-three Representatives from the project partner institutes were in attendance at the meeting.
Professor Burkert Pieske, scientific coordinator of the sysVASC project, welcomed the attendants and presented an introduction to both the consortiums aims and the basis of the project. He underlined the difficulties in detecting cardiovascular disease and the limited understanding of disease development despite the fact that it remains the number one cause of death worldwide. Prof. Pieske introduced the sysVASC project as an integrative systems biology approach to meet the desperate need for novel means of detection and therapy. He emphasized close cooperation and communication as a basis for the combination of multiple disciplines and strongly interdependent work packages.
Project partners were then each given the opportunity during the course of the meeting to present their road map of activities for the first year to the consortium as a whole, as well as in small discussion groups.
The consortium recognized that data sharing, availability, phenotypes and multi-omics data sets are challenges within the project that will require close cooperation in order to be met. During the meeting they developed strategies for streamlining these challenges in order to be able to work together most effectively from the very start of the project.